Dear Expectant Parent:

Where to bank your infant's cord blood and cord tissue may seem like a daunting decision with all of the cord blood banks making different claims.

You want to find a solid company using proven techniques to process and store your infant's cord blood and cord tissue. This is an exciting and important investment in your baby's future, so you need to feel confident that M.A.Z.E. Cord Blood Laboratories will meet your needs now and in the future.

M.A.Z.E. Cord Blood Laboratories has been financially solvent since its inception in 2004. The company has generated positive cash flow from the beginning. We follow a different business model from most cord blood banks, providing state-of-the-art technology at an affordable price. This has been popular, with the company growing at a 50% rate each year since its launch.

Our business is dedicated to taking care of your infant's cord blood. We leave research to the universities. We don't want to experiment with our patients' cord blood and cord tissue; we use proven storage techniques. This avoids risky research investments that might result in huge losses, endangering the corporate parent. We also spend very little on advertising, marketing, and sales. While you won't find any television, radio or big glossy magazine advertisements from M.A.Z.E. Cord Blood, our patients recognize that they are saving hundreds if not thousands of dollars since they are not paying for advertisements. They would rather pay for what counts -- the quality processing and storage.

M.A.Z.E. Cord Blood's parent company, M.A.Z.E. Laboratories, has been in existence since 1997, making it older than any of the leading cord blood banks. The financial success of M.A.Z.E. Laboratories has been well established for 10 years. Since its founding, annual growth has been steady and reliable, with positive cash flow from operations.

There are several factors that have made M.A.Z.E. Cord Blood Laboratories so financially stable and successful. First, we do not borrow to expand our business. Unlike many cord blood companies, we are not willing to spend money we do not have. Second, we invest in the quality of care of your infant's cord blood. Rather than spending on heavy marketing and sales, we provide state-of-the-art processing and storage. If a better scientific technique is perfected, we will migrate to that technique. That is why our processes are state-of-the-art, but you won't find our ads in the latest pregnancy magazine.

I am proud to be part of a company that has such a focus on its patients. Our entire management team is dedicated to ensuring an exceptional experience for every patient while trying to manage patient costs in these times of runaway health-care costs.

Sincerely,
Bat Sheva Marcus, MPH, PhD
Chief Operating Officer